Skip to main content
Figure 2 | BMC Anesthesiology

Figure 2

From: Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial

Figure 2

Severity of nausea over 48 postoperative hours, graded using a 10-point visual analogue scale (VAS), in the female patients who underwent laparoscopic gynaecologic surgery. The data are expressed as mean ± standard error values of the mean. *P < 0.05, compared with group P. Group P was given 0.075 mg of palonosetron intravenously, whereas group A was given 40 mg of oral aprepitant.

Back to article page